Your prediction
Pluristem Therapeutics Inc. Stock
For the coming years our community has positive and negative things to say abot the Pluristem Therapeutics Inc. stock. Criterium "Revenue growth" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Pluristem Therapeutics Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Pluristem Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pluristem Therapeutics Inc. | - | - | - | - | - | - | - |
| Enlivex Therapeutics Ltd. | -1.550% | 1.058% | 5.525% | 3.243% | 56.557% | -73.560% | -92.597% |
| Oramed Pharmaceuticals | -1.200% | 3.922% | 0.662% | 42.266% | 19.093% | 48.217% | -60.110% |
| Heron Therapeutics Inc. | 6.950% | -10.600% | -27.845% | -44.230% | -19.749% | -58.544% | -93.972% |